109 related articles for article (PubMed ID: 23299313)
1. Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL.
Naderi EH; Ugland HK; Diep PP; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Blood; 2013 Mar; 121(10):1805-13. PubMed ID: 23299313
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.
Naderi EH; Skah S; Ugland H; Myklebost O; Sandnes DL; Torgersen ML; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Mol Cancer; 2015 Jan; 14(1):14. PubMed ID: 25623255
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cells in vitro.
Safa M; Kazemi A; Zaker F; Razmkhah F
J Recept Signal Transduct Res; 2011 Jun; 31(3):256-63. PubMed ID: 21619452
[TBL] [Abstract][Full Text] [Related]
4. Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation.
Naderi EH; Findley HW; Ruud E; Blomhoff HK; Naderi S
Blood; 2009 Jul; 114(3):608-18. PubMed ID: 19451550
[TBL] [Abstract][Full Text] [Related]
5. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
[TBL] [Abstract][Full Text] [Related]
6. Hyperactivation of NF-κB via the MEK signaling is indispensable for the inhibitory effect of cAMP on DNA damage-induced cell death.
Kloster MM; Naderi EH; Carlsen H; Blomhoff HK; Naderi S
Mol Cancer; 2011 Apr; 10():45. PubMed ID: 21510868
[TBL] [Abstract][Full Text] [Related]
7. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Davies C; Hogarth LA; Mackenzie KL; Hall AG; Lock RB
Cell Cycle; 2015; 14(22):3602-12. PubMed ID: 26506264
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia.
Sędek Ł; Theunissen P; Sobral da Costa E; van der Sluijs-Gelling A; Mejstrikova E; Gaipa G; Sonsala A; Twardoch M; Oliveira E; Novakova M; Buracchi C; van Dongen JJM; Orfao A; van der Velden VHJ; Szczepański T;
J Immunol Methods; 2019 Dec; 475():112429. PubMed ID: 29530508
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma.
Onda K; Iijima K; Katagiri YU; Okita H; Saito M; Shimizu T; Kiyokawa N
Int J Hematol; 2010 Jun; 91(5):808-19. PubMed ID: 20428981
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.
Buske C; Becker D; Feuring-Buske M; Hannig H; Wulf G; Schäfer C; Hiddemann W; Wörmann B
Leukemia; 1997 Mar; 11(3):386-92. PubMed ID: 9067578
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.
Perez DR; Smagley Y; Garcia M; Carter MB; Evangelisti A; Matlawska-Wasowska K; Winter SS; Sklar LA; Chigaev A
Oncotarget; 2016 Jun; 7(23):33960-82. PubMed ID: 27129155
[TBL] [Abstract][Full Text] [Related]
12. PI3K/AKT and Mdm2 activation are associated with inhibitory effect of cAMP increasing agents on DNA damage-induced cell death in human pre-B NALM-6 cells.
Ghorbani A; Jeddi-Tehrani M; Saidpour A; Safa M; Bayat AA; Zand H
Arch Biochem Biophys; 2015 Jan; 566():58-66. PubMed ID: 25524737
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells.
Richartz N; Pietka W; Yadav A; Bostad M; Bhagwat S; Naderi S; Naderi EH; Stokke T; Ruud E; Blomhoff HK
J Biol Chem; 2024 Jan; 300(1):105509. PubMed ID: 38042493
[TBL] [Abstract][Full Text] [Related]
14. cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53.
Skah S; Richartz N; Duthil E; Gilljam KM; Bindesbøll C; Naderi EH; Eriksen AB; Ruud E; Dirdal MM; Simonsen A; Blomhoff HK
Oncotarget; 2018 Jul; 9(54):30434-30449. PubMed ID: 30100998
[TBL] [Abstract][Full Text] [Related]
15. Understanding the reconstitution of the B-cell compartment in bone marrow and blood after treatment for B-cell precursor acute lymphoblastic leukaemia.
Theunissen PMJ; van den Branden A; Van Der Sluijs-Gelling A; De Haas V; Beishuizen A; van Dongen JJM; Van Der Velden VHJ
Br J Haematol; 2017 Jul; 178(2):267-278. PubMed ID: 28542787
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
Oh L; Hainaut P; Blanchet S; Ariffin H
BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues.
Safa M; Kazemi A; Zand H; Azarkeivan A; Zaker F; Hayat P
Apoptosis; 2010 Feb; 15(2):196-203. PubMed ID: 19882354
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of human B cell precursor-leukemia cell lines.
Matsuo Y; Drexler HG
Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106
[TBL] [Abstract][Full Text] [Related]
19. The role of cyclic-3',5'-adenosine monophosphate in prostaglandin-mediated inhibition of basic calcium phosphate crystal-induced mitogenesis and collagenase induction in cultured human fibroblasts.
McCarthy GM; Cheung HS
Biochim Biophys Acta; 1994 Apr; 1226(1):97-104. PubMed ID: 7512387
[TBL] [Abstract][Full Text] [Related]
20. Increased μ-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis.
Mikosik A; Henc I; Ruckemann-Dziurdzińska K; Frąckowiak JE; Płoszyńska A; Balcerska A; Bryl E; Witkowski JM
PLoS One; 2015; 10(8):e0136615. PubMed ID: 26317226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
